Systemic Inflammatory Response Syndrome
Systemic Inflammatory Response Syndrome
is an inflammatory state affecting the whole body, frequently a response of the immune system to infection, but not necessarily so. It is related to sepsis, a condition in which individuals both meet criteria for SIRS and have a known or highly suspected infection.
According to Brunner: A syndrome resulting from a severe clinical insult that initiates an overwhelming inflammatory response by the body.
Systemic Inflammatory Response Syndrome(SIRS) o Widespread inflammatory response o Two or more of the following Temp > 38C or 36C Heart Rate > 90 bpm Tachypnea (RR > 20) PCO2 <32 WBC > 12,000 cells/mm3, < 4000 cells/mm3 or presence of >10% immature neutrophils
Pathophysiology of SIRS
Cytokines
Are Intercellular signaling proteins or messengers More than 30 recognized Act through binding to specific receptors on the target cells triggering other cascades or its own cascade
Pathophysiology of SIRS
Pathophysiology of SIRS
TNF-
The earliest and most potent mediator in SIRS It activates neutrophils, causing the production of Interleukin-1(IL-1), Interleukin-6 (INL-6), and Interleukin -8 (INL-8). It stimulates platelet activating factors and prostaglandin, and promotes leukocyte or vessel cell wall adhesion.
Pathophysiology of SIRS
IL-1
Pathophysiology of SIRS
During an inflammatory response, it facilitates the movement of WBCs toward the injury, ischemia, or infected area It stimulates the release of arachidonic acid from phospholipids in the plasma membranes, leading to fever, hypotension, and decrease systemic vascular resistance. IL-1 also leads to muscle protein breakdown IL-1 works with other cellular immunity components to produce IL-2, which decreases blood pressure, systemic vascular resistance, and left ventricular ejection fraction. IL-2 may also increase left ventricular end diastolic volume, cardiac output, and heart rate
Pathophysiology of SIRS
IL-6
Is a key messenger that can either trigger the rest of the cascade or its arrest Stimulates the release of acute phase reactors Its serum levels are consistent with the gravity of the immune reaction
Nitric Oxide
Nitric oxide is synthesized by inducible nitric oxide synthase (iNOS) in the vascular endothelium and smooth muscle in response to pro-inflammatory cytokines NO is the vasoactive mediator responsible for the fall in systemic vascular resistance underlying the hypotension in the late stages of SIRS and septic shock
Pathophysiology of SIRS
Thromboxane A2
Is a potent vasoconstrictor and platelet aggregator Leads to tissue ischemia from hypoperfusion.
Capillary endothelial permeability Bronchoconstriction Activation of neutrophils
Leukotrienes leads to
Pathophysiology of SIRS
Pathophysiology of SIRS
Clotting Cascade
Fibrin is formed due to the injury of the vascular endothelium Chemical mediators stimulate the release of Hageman Factor and Thromboplastin These form clots at the site of the injury, attempting to stabilize the site Fibrinolysis is activated by the coagulation cascade, leading to mediator induced (DIC).
Pathophysiology of SIRS
Bradykinin
The activation of the Hageman Factor stimulates the release of bradykinin Bradykinin creates vasodilatation and capillary leakage, therefore volume depletion.
Pathophysiology of SIRS
Myocardial depressant factor is a serum protein released by the hypoperfused and ischemic cells of the pancreas It decreases the velocity of contractions of myocardial cells, leading to decreased right and left ventricular ejection fractions
Pathophysiology of SIRS
Beta Endorphins
Beta endorphins are released, by the pituitary and hypothalamus, in response to hypoperfusion They cause peripheral vasodilatation, and decrease cardiac contractility
Pathophysiology of SIRS
Stages of SIRS
Pathophysiology of SIRS
SIRS 1
Stages
Pathophysiology of SIRS
SIRS 2
Stages
Pathophysiology of SIRS
SIRS 3
Stages
Pathophysiology of SIRS
SIRS 4
Stages
Most patients do not make it this far --but if they do- A compensatory anti-inflammatory response occurs trying to suppress inflammation
Clinical Picture
Clinical Picture
Organ Manifestations
Cardiovascular
Skin warm and flushed Widened pulse pressure Cardiac output is but SVR is Eventually C.O. declines exacerbating hypoperfusion
Clinical Picture
Organ Manifestations
Pulmonary
Hypoxemia may be masked by hyperventilation Respiratory alkalosis Pulmonary edema Respiratory failure Bronchoconstriction ARDS
Clinical Picture
Organ Manifestations
CNS
Altered mental status Confusion Irritability Agitation Disorientation Lethargy Seizures Coma
Renal
Oliguria: < 500 ml/day Metabolic Acidosis
Clinical Picture
Organ Manifestations
GIT
Impaired motility SGPT & SGOT Hyperbilirubinemia Hepatic necrosis Hypoprothrombin emia Hypoglycemia
Blood
or WBCs PT and PTT or Platelets Anemia
Diagnostic
Cytokines assay (IL-6, IL-8 & TNF) Blood Culture Serum Procalcitonin
The only lab test that differentiates
SIRS (0.5 -2 ng/dl) from Sepsis (>2 & <10 ng/dl) from MOD (>10 and often >100ng/dl)
Prognosis
Death in 60% of cases of late stages & shock in patients with no previous history of medical conditions Death rate is higher if MOD develops & is dependant on no. of organs affected
3 organs 85% 4 organs 95% 5 organs 99%
Medical Management
Identification and Elimination of the cause Potential routes of further infection are removed Fluid replacement
Nursing Management
Strictly adhere with aseptic technique like hand washing Nurse continuously monitor the patients Vital signs Intake and output Nutritional status
Thank You